Transcode Therapeutics appoints Anna Moore as Chair of Scientific Advisory

TransCode Therapeutics (RNAZ) appointed Anna Moore as Chair of its Scientific Advisory Board. Moore, Associate Dean for Research Development, Director of the Precision Health Program and Professor in the Departments of Radiology and Physiology at Michigan State University, is a co-founder of TransCode Therapeutics and expert in molecular imaging and RNA-targeted cancer therapeutics. Prior to joining MSU, she had a 26-year career at Massachusetts General Hospital and Harvard Medical School, where she served as Professor of Radiology and Director of the Molecular Imaging Laboratory.